FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roxana Schillaci

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Physiology

Anatomy

Co-author Network

Publications

TOP 3
María C Diaz Flaqué; Franco Izzo; Cecilia J Proietti; Roxana Schillaci; Rocío Vicario; Patricia V Elizalde
Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.
Mercedes Tkach; Wendy Beguelin; Ernesto Gil Deza; María Celeste Díaz Flaqué; Patricia V Elizalde; Felipe G Gercovich; Pablo Guzmán; Esteban Maronna; María Florencia Mercogliano; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.
Mercedes Tkach; Wendy Beguelin; Juliana Cassataro; Eduardo H Charreau; Lorena Coria; María Celeste Díaz Flaqué; Patricia V Elizalde; Isabel Frahm; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roxana Schillaci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: María C Diaz Flaqué; Franco Izzo; Cecilia J Proietti; Roxana Schillaci; Rocío Vicario; Patricia V Elizalde
Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.
Steroids 2013;78(6):559-67.
2013: Mercedes Tkach; Wendy Beguelin; Ernesto Gil Deza; María Celeste Díaz Flaqué; Patricia V Elizalde; Felipe G Gercovich; Pablo Guzmán; Esteban Maronna; María Florencia Mercogliano; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.
Endocrine-related cancer 2013;20(2):197-212.
2012: Mercedes Tkach; Wendy Beguelin; Juliana Cassataro; Eduardo H Charreau; Lorena Coria; María Celeste Díaz Flaqué; Patricia V Elizalde; Isabel Frahm; Cecilia J Proietti; Martin Alfredo Rivas; Cinthia Rosemblit; Roxana Schillaci
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(3):1162-72.
2012: Martin Alfredo Rivas; Roxana Schillaci; Leandro Venturutti; Tim Hui-Ming Huang; Yi-Wen Huang; Patricia V Elizalde
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Breast cancer research : BCR 2012;14(3):R77.
2012: Roxana Schillaci; Wendy Beguelin; Florencia Cayrol; Eduardo H Charreau; María C Díaz Flaqué; Isabel Frahm; Pablo Guzmán; Esteban Maronna; Jorge Palazzi; Viviana Pineda; Cecilia J Proietti; Juan C Roa; Patricia V Elizalde
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.
BMC cancer 2012;12():74.
2011: Cecilia J Proietti; Wendy Béguelin; María Celeste Díaz Flaqué; Florencia Cayrol; Martin Alfredo Rivas; Mercedes Tkach; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.
Steroids 2011;76(4):381-92.
2010: Wendy Béguelin; María Celeste Díaz Flaqué; Cecilia J Proietti; Florencia Cayrol; Martin Alfredo Rivas; Mercedes Tkach; Cinthia Rosemblit; Johanna M Tocci; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.
Molecular and cellular biology 2010;30(23):5456-72.
2010: Martin Alfredo Rivas; Mercedes Tkach; Wendy Beguelin; Cecilia J Proietti; Cinthia Rosemblit; Eduardo H Charreau; Patricia V Elizalde; Roxana Schillaci
Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
Breast cancer research and treatment 2010;122(1):111-24.
2009: Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Martin Alfredo Rivas; María Celeste Díaz Flaqué; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.
Molecular and cellular biology 2009;29(5):1249-65.
2008: Martin Alfredo Rivas; Romina Carnevale; Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Mariana Salatino; Eduardo H Charreau; Isabel Frahm; Sandra Sapia; Peter Brouckaert; Patricia V Elizalde; Roxana Schillaci
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Experimental cell research 2008;314(3):509-29.
2007: Romina Carnevale; Cecilia J Proietti; Mariana Salatino; Alejandro J Urtreger; Guillermo Peluffo; Dean P Edwards; Viroj Boonyaratanakornkit; Eduardo H Charreau; Elisa Bal de Kier Joffé; Roxana Schillaci; Patricia V Elizalde
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Molecular endocrinology (Baltimore, Md.) 2007;21(6):1335-58.
2006: Mariana Salatino; W Beguelin; M G Peters; Romina Carnevale; Cecilia J Proietti; M D Galigniana; Cleber Giovane Vedoy; Roxana Schillaci; Eduardo H Charreau; Mari C Sogayar; Patricia V Elizalde
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
Oncogene 2006;25(59):7723-39.
2006: Roxana Schillaci; Mariana Salatino; Juliana Cassataro; Cecilia J Proietti; Guillermo H Giambartolomei; Martin Alfredo Rivas; Romina Carnevale; Eduardo H Charreau; Patricia V Elizalde
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(6):3426-37.
2005: Roxana Schillaci; Adriana Galeano; Damasia Becu-Villalobos; Olga Spinelli; Sandra Sapia; Raimundo F Bezares
Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
British journal of haematology 2005;130(1):58-66.
2005: Cecilia J Proietti; Mariana Salatino; Cinthia Rosemblit; Romina Carnevale; Adali Pecci; Alberto R Kornblihtt; Alfredo A Molinolo; Isabel Frahm; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Molecular and cellular biology 2005;25(12):4826-40.
2004: Mariana Salatino; Roxana Schillaci; Cecilia J Proietti; Romina Carnevale; Isabel Frahm; Alfredo A Molinolo; Adolfo Iribarren; Eduardo H Charreau; Patricia V Elizalde
Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Oncogene 2004;23(30):5161-74.
2004: Mariana Salatino; Roxana Schillaci; Cecilia J Proietti; Romina Carnevale; Eduardo H Charreau; Patricia V Elizalde
[Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer].
Medicina 2004;64(2):129-34.
2003: María Eugenia Segretin; Adriana Galeano; Alicia Roldán; Roxana Schillaci
Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes.
Hormone research 2003;59(6):276-80.
2002: Eleonora M Sorianello; Roxana Schillaci; Astrid Chamson-Reig; Victoria A Lux-Lantos; Carlos Libertun
Actions of immunosuppressor drugs on the development of an experimental ovarian tumor.
Experimental biology and medicine (Maywood, N.J.) 2002;227(8):658-64.
2001: MG Brocardo; Roxana Schillaci; Adriana Galeano; Martín Radrizzani; V White; A G Guerrico; Tomás Santa Coloma; Alicia Roldán
Early effects of insulin-like growth factor-1 in activated human T lymphocytes.
Journal of leukocyte biology 2001;70(2):297-305.
2001: Mariana Salatino; Leticia Labriola; Roxana Schillaci; Eduardo H Charreau; Patricia V Elizalde
Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Experimental cell research 2001;265(1):152-66.
1998: Roxana Schillaci; MG Brocardo; Adriana Galeano; Alicia Roldán
Downregulation of insulin-like growth factor-1 receptor (IGF-1R) expression in human T lymphocyte activation.
Cellular immunology 1998;183(2):157-61.
1997: Alicia Roldán; S Gogg; Monica G Ferrini; Roxana Schillaci; Alejandro F de Nicola
Glucocorticoid regulation of in vitro astrocyte phagocytosis.
Biocell : official journal of the Sociedades Latinoamericanas de Microscopía Electronica ... et. al 1997;21(1):83-9.
1995: Roxana Schillaci; M G Brocardo; Alicia Roldán
Co-operative effect between insulin-like growth factor-1 and interleukin-2 on DNA synthesis and interleukin-2 receptor-alpha chain expression in human lymphocytes.
Immunology and cell biology 1995;73(4):340-5.
1994: Roxana Schillaci; C M Ribaudo; cristina Rondinone; Alicia Roldán
Role of insulin-like growth factor-1 on the kinetics of human lymphocytes stimulation in serum-free culture medium.
Immunology and cell biology 1994;72(4):300-5.
1994: Roxana Schillaci; E M Eugui; Alicia Roldán
Insulin effect on interleukin 1 (IL-1) and interleukin 6 (IL-6) production by lipopolysaccharide-stimulated human monocytes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1994;26(2):113-5.
1991: cristina Rondinone; Roxana Schillaci; M B Castillo; Alicia Roldán
Inhibitory effect of 11 beta-hydroxypregna-1,4-diene-3,20-dione (delta HOP) on lymphocyte proliferation.
Clinical and experimental immunology 1991;86(2):311-4.
1989: A Roldan; E Charreau; Roxana Schillaci; E M Eugui; A C Allison
Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin.
Immunology letters 1989;20(1):5-8.
1989: cristina Rondinone; Roxana Schillaci; Carlos P Lantos; Alicia Roldán
Appearance and persistence of 11 beta-hydroxypregna-1,4-diene-3,20-dione (delta HOP) effect "in vivo".
Acta physiologica et pharmacologica latinoamericana : organo de la Asociación Latinoamericana de Ciencias Fisiológicas y de la Asociación Latinoamericana de Farmacología 1989;39(2):181-8.
1986: M B Castillo; Roxana Schillaci; Alicia Roldán
Antagonistic effect of insulin and cortisol on stimulated lymphocytes.
Medicina 1986;46(4):445-8.